Primary Site >> Colorectal Cancer

Gene >> ALPK1

Journal: Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):788-96.
Title: [Adoptive immunotherapy of malignant disease using LAK cells].
Author: Kimoto, Y|Taguchi, T
PMID: 3260466
Journal: Cancer Treat Rev. 1989 Jun;16 Suppl A:163-7.
Title: A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma.
Author: Hamblin, T J|Inzani, V|Sadullah, S|Stevenson, F K|Williamson, P|van der Plas, J|Palmer, P|Franks, C R
PMID: 2670212
Journal: Nihon Gan Chiryo Gakkai Shi. 1989 May 20;24(5):1027-33.
Title: [Potent effects of the prostaglandin synthesis inhibitor indomethacin on the cellular immune response in gastrointestinal cancer patients].
Author: Koyama, H|Narisawa, T|Kodama, M|Ishikawa, K|Kusaka, H|Yamazaki, Y|Koyama, K
PMID: 2778378
Journal: Onkologie. 1990 Dec;13(6):416-22.
Title: The clinical significance of interleukin-2.
Author: Bergmann, L
PMID: 2092277
Journal: Scand J Immunol. 1990 Mar;31(3):275-82.
Title: Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granular lymphocytes.
Author: Yagita, M|Saksela, E
PMID: 2108487
Journal: Int J Cancer. 1990 Dec 15;46(6):1021-8.
Title: Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
Author: Pendurthi, T K|Parker, R|Schlom, J|Primus, F J
PMID: 2123477
Journal: Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 2):902-6.
Title: [Immunotherapy and quality of life].
Author: Ochiai, T|Suzuki, T|Gunji, Y|Okuyama, K|Koide, Y|Isono, K
PMID: 2344201
Journal: Int J Cancer. 1991 Mar 12;47(5):746-54.
Title: The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype.
Author: Rivoltini, L|Cattoretti, G|Arienti, F|Mastroianni, A|Melani, C|Colombo, M P|Parmiani, G
PMID: 1706327
Journal: Nat Immun Cell Growth Regul. 1991;10(6):308-19.
Title: Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells.
Author: Rodolfo, M|Salvi, C|Bassi, C|Rovetta, G|Melani, C|Colombo, M P|Parmiani, G
PMID: 1787836
Journal: Gan To Kagaku Ryoho. 1991 Sep;18(12):2117-20.
Title: [Effect of UFT by oral administration using a murine hepatic metastasis model].
Author: Yunoki, S|Hizuta, A|Sou, J|Takahashi, M|Nagata, Y|Yamamoto, M|Kataoka, K|Matumoto, M|Kawaguchi, H|Miyagi, K
PMID: 1888182
Journal: Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1229-33.
Title: [Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases].
Author: Okuno, K|Onishi, H|Nakajima, I|Shirayama, Y|Hirohata, T|Ozaki, M|Yasutomi, M
PMID: 1944193
Journal: Int J Biol Markers. 1992 Jul-Sep;7(3):143-7.
Title: CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes.
Author: Rivoltini, L|Cattoretti, G|Arienti, F|Mastroianni, A|Parmiani, G
PMID: 1431336
Journal: Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1453-6.
Title: [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
Author: Miya, K|Saji, S|Furuta, T|Azuma, S|Umemoto, T|Takao, H|Katou, M|Kanno, A|Kaneda, N|Yamawaki, Y
PMID: 1530292
Journal: Biotherapy. 1992;4(4):257-65.
Title: Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer.
Author: Okuno, K|Ohnishi, H|Koh, K|Shindo, H|Yoshioka, H|Yasutomi, M
PMID: 1622739
Journal: Int J Cancer. 1993 Feb 1;53(3):409-17.
Title: Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.
Author: Blottiere, H M|Zennadi, R|Gregoire, M|Aillet, G|Denis, M G|Meflah, K|Le Pendu, J
PMID: 8428794
Journal: Zhonghua Zhong Liu Za Zhi. 1994 Nov;16(6):428-31.
Title: [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients].
Author: Cao, G W|Yang, W G|Du, P
PMID: 7720497
Journal: Int J Cancer. 1994 May 1;57(3):341-7.
Title: CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis.
Author: Kammerer, R|von Kleist, S
PMID: 8168994
Journal: Wien Med Wochenschr. 1995;145(2-3):47-50.
Title: [Autologous bone marrow transplantation in intestinal carcinoma].
Author: Sebesta, C|Tiefengraber, E|Kier, P|Ruckser, R|Habertheuer, K H|Schmid, A|Hinterberger, W
PMID: 7762252
Journal: Eur J Surg Oncol. 1995 Jun;21(3):254-60.
Title: Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer.
Author: Purasiri, P|Ashby, J|Heys, S D|Eremin, O
PMID: 7781792
Journal: Eur J Cancer. 1995 Dec;31A(13-14):2324-9.
Title: The influence of the local environment on tissue architecture of colorectal carcinoma (CRC) cell aggregates and its consequence for tumour attack by lymphocytes in vitro and in vivo.
Author: Kammerer, R|von Kleist, S
PMID: 8652264
Journal: Scand J Immunol. 1997 Feb;45(2):182-92.
Title: Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.
Author: Maeurer, M J|Walter, W|Martin, D|Zitvogel, L|Elder, E|Storkus, W|Lotze, M T
PMID: 9042431
Journal: Int J Cancer. 1997 Jul 3;72(1):142-8.
Title: Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal-carcinoma cells.
Author: Luo, J S|Kammerer, R|Schultze, H|von Kleist, S
PMID: 9212235
Journal: Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):493-500.
Title: Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients.
Author: Eckert, K|Grunberg, E|Garbin, F|Maurer, H R
PMID: 9637344
Journal: Russ J Immunol. 1997 Dec;2(3-4):167-176.
Title: IL-2-Activated Killer Cells and Native Cytokines in Treatment of Patients with Advanced Cancer.
Author: Ostanin, Alexander A.|Chernykh, Helena R.|Leplina, Olga Y.|Shevela, Ekaterina Ya.|Niconov, Sergey D.|Kozlov, Vladimir A.
PMID: 12687071
Journal: Int J Oncol. 1997 Mar;10(3):481-6.
Title: Effects of thymic peptides, in vitro, on the impaired immunocytotoxicity of peripheral blood mononuclear cells from tumor patients.
Author: Eckert, K|Mayer, G|Stange, R|Kalden, M|Krasagakis, K|Maurer, H
PMID: 21533400
Journal: Oncol Rep. 1997 Nov-Dec;4(6):1343-7.
Title: Low molecular thymic peptides improve the deficient immunocytotoxicity of mononuclear cells from tumor patients in vitro.
Author: Klaus, E|Stange, R|Kalden, M|Krasagakis, K|Maurer, H
PMID: 21590251
Journal: Int J Oncol. 1998 Apr;12(4):957-63.
Title: Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro.
Author: Grunberg, E|Eckert, K|Maurer, H R
PMID: 9499461
Journal: Cell Immunol. 2000 Aug 1;203(2):84-94.
Title: Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells.
Author: Kwak, J Y|Han, M K|Choi, K S|Park, I H|Park, S Y|Sohn, M H|Kim, U H|McGregor, J R|Samlowski, W E|Yim, C Y
PMID: 11006006
Journal: Sci Rep. 2016 Jun 10;6:27350.
Title: Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers.
Author: Liao, Hsien-Feng|Lee, Hsien-Hsiung|Chang, Ya-Sian|Lin, Chia-Li|Liu, Ting-Yuan|Chen, Yu-Chia|Yen, Ju-Chen|Lee, Ya-Ting|Lin, Chien-Yu|Wu, Shih-Hsiung|Ko, Ying-Chin|Chang, Jan-Gowth
PMID: 27283888